PRESERVE Trademark

Trademark Overview

On Thursday, December 15, 2022, a trademark application was filed for PRESERVE with the United States Patent and Trademark Office. The USPTO has given the PRESERVE trademark a serial number of 97719367. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Wednesday, July 24, 2024. This trademark is owned by Paragon 28, Inc.. The PRESERVE trademark is filed in the Pharmaceutical Products category with the following description:

Human bone and tissue allografts for use in the foot and ankle
preserve

General Information

Serial Number97719367
Word MarkPRESERVE
Filing DateThursday, December 15, 2022
Status760 - EX PARTE APPEAL PENDING
Status DateWednesday, July 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesHuman bone and tissue allografts for use in the foot and ankle

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 12, 2023
Primary Code005
First Use Anywhere DateTuesday, January 31, 2017
First Use In Commerce DateTuesday, January 31, 2017

Trademark Owner History

Party NameParagon 28, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEnglewood, CO 80112

Trademark Events

Event DateEvent Description
Monday, December 19, 2022NEW APPLICATION ENTERED
Thursday, January 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 7, 2023ASSIGNED TO EXAMINER
Wednesday, September 13, 2023NON-FINAL ACTION WRITTEN
Wednesday, September 13, 2023NON-FINAL ACTION E-MAILED
Wednesday, September 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 26, 2023ASSIGNED TO EXAMINER
Monday, December 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 2, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 2, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 3, 2024FINAL REFUSAL WRITTEN
Wednesday, April 3, 2024FINAL REFUSAL E-MAILED
Wednesday, April 3, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 3, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, July 3, 2024EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, July 3, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, July 3, 2024EX PARTE APPEAL-INSTITUTED
Tuesday, July 23, 2024SUBSEQUENT FINAL EMAILED
Tuesday, July 23, 2024NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Tuesday, July 23, 2024SUBSEQUENT FINAL REFUSAL WRITTEN

Related Keywords

preserve foot ankle allografts tissue bone human